Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction
Table 1
Comparison of the demographics and cycle outcome.
Demographics and cycle outcome
Group 1 (nAMH/nFSH)
Group 2 (nAMH/hFSH)
Group 3 (lAMH/nFSH)
Group 4 (lAMH/hFSH)
value
*Age (years)
34 (32–38)
33 (32-33)
37 (34–39)
37 (35–39)
0.0005
*BMI (kg/m2)
25 (23–27)
23 (21–28)
22 (21–23)
24 (23–28)
0.27
*AMH (pmol/L)
13.1 (7.38–27.4)
8.8 (6.8–13.1)
2.2 (0.7–3.9)
1.4 (0.4–3.1)
<0.0001
*FSH (IU/L)
7.1 (6–8.2)
12.54 (10.7–18)
8 (6.4–10)
12 (11.2–32.9)
<0.0001
*COH (days)
14 (14-15)
14 (13–15)
14 (13–16)
15 (14–16)
0.87
*FSH dose (IU)
3600 (2250–4200)
3300 (2250–4299)
4200 (3000–4500)
4500 (4200–4800)
0.0008
*No. of oocytes retrieved
7 (5–10)
3 (2–7)
4 (3–6)
4 (2–6)
0.0023
**Cycles cancelled (%)
1 (2%)
0
2 (5%)
1 (4%)
0.90
BMI: body mass index, COH: controlled ovarian hyperstimulation, and OR: ovarian reserve. *Values presented as median with interquartile range in parenthesis. **Numbers with percentages in parenthesis.
